Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: Effect of clinical node status at presentation

Journal of the American College of Surgeons

Volumn 199, Issue 6, 2004, Pages 856-862

  Lang, Julie E ^a   Esserman, Laura J ^a   Ewing, Cheryl A ^a   Rugo, Hope S ^b   Lane, Karen T ^a   Leong, Stanley P ^a   Hwang, E Shelley ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACCURACY; ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CONTROLLED STUDY; HUMAN; LYMPHADENECTOMY; PREDICTION; PRIORITY JOURNAL; SELECTIVE SENTINEL LYMPHADENECTOMY; SENTINEL LYMPH NODE; TREATMENT FAILURE;

AXILLA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 8844264588     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2004.08.023     Document Type: Article

References (29)

1. D. Ivens, A.L. Hoe, T.J. Podd Assessment of morbidity from complete axillary dissection Br J Cancer 66 1992 136 138
2. S.P. Leong, E.T. Morita, P.A. Treseler Multidisciplinary approach to selective sentinel lymph node mapping in breast cancer Breast Cancer 7 2000 105 113
3. A.E. Giuliano, P.I. Haigh, M.B. Brennan Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer J Clin Oncol 18 2000 2553 2559
4. P. Haigh, A. Giuliano Sentinel lymphadenectomy in node negative breast cancer Cancer Treat Res 103 2000 25 37
5. C. Reynolds, R. Mick, J.H. Donohue Sentinel lymph node biopsy with metastasis can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 17 1999 1720 1726
6. U. Veronesi, G. Paganelli, G. Viale A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 2003 546 553
7. E.P. Mamounas Neoadjuvant chemotherapy for operable breast cancer is this the future? Clin Breast Cancer 1 4 Suppl 2003 S10 S19
8. I.C. Smith, S.D. Heys, A.W. Hutcheon Neoadjuvant chemotherapy in breast cancer significantly enhanced response with docetaxel J Clin Oncol 20 2002 1456 1466
9. E.P. Mamounas Present state and future prospects a review of cooperative groups' adjuvant and neoadjuvant trials in breast cancer Clin Breast Cancer 1 2 Suppl 2001 S20 S30
10. B. Fisher, J. Bryant, N. Wolmark Effect of preoperative chemotherapy on the outcome of women with operable breast cancer J Clin Oncol 16 1998 2672 2685
11. H.M. Kuerer, K.K. Hunt, L.A. Newman Neoadjuvant chemotherapy in women with invasive breast carcinoma conceptual basis and fundamental surgical issues J Am Coll Surg 190 2000 350 363
12. K.S. Nason, B.O. Anderson, D.R. Byrd Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma Cancer 89 2000 2187 2194
13. M.S. Sabel, A.F. Schott, C.G. Kleer Sentinel node biopsy prior to neoadjuvant chemotherapy Am J Surg 186 2003 102 105
14. H.M. Kuerer, A.A. Sahin, K.K. Hunt Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy Ann Surg 230 1999 72 78
15. J.Y. Pierga, E. Mouret, V. Dieras Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer Br J Cancer 83 2000 1480 1487
16. N. Wolmark, J. Wang, E. Mamounas Preoperative chemotherapy in patients with operable breast cancer nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18 J Natl Cancer Inst Monogr 30 2001 96 102
17. H. Cure, S. Amat, F. Penault-Llorca Prognostic value of residual node involvement in operable breast cancer after induction chemotherapy Breast Cancer Res Treat 76 2002 37 45
18. G.F. Schwartz, A.E. Giuliano, U. Veronesi Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast Hum Pathol 33 2002 579 589 April 19-22, 2001, Philadelphia, PA
19. E.P. Mamounas Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer Updated results from NSABP B-27 ASCO 140 2002 [Abstract]
20. R. Reitsamer, F. Peintinger, L. Rettenbacher Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy J Surg Oncol 84 2003 63 67
21. G.C. Balch, S.K. Mithani, K.R. Richards Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer Ann Surg Oncol 10 2003 616 621
22. A.R. Miller, V.E. Thomason, I.T. Yeh Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma Ann Surg Oncol 9 2002 243 247
23. J.R. Piato, A.C. Barros, K.M. Pincerato Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study Eur J Surg Oncol 29 2003 118 120
24. E.W. Brady Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer Breast J 8 2002 97 100
25. T.B. Julian, N. Patel, D. Dusi Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer Am J Surg 182 2001 407 410
26. A. Fernandez, M. Cortes, E. Benito Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme Nucl Med Commun 22 2001 361 366
27. T.M. Breslin, L. Cohen, A. Sahin Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer J Clin Oncol 18 2000 3480 3486
28. V. Stearns, C.A. Ewing, R. Slack Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer Ann Surg Oncol 9 2002 235 242
29. S. Kang, S. Kim, Y. Kwon Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy San Antonio Breast Cancer Symposium 2003 San Antonio, TX